PT - JOURNAL ARTICLE AU - Mosley, Mary ED - Quyyumi, Arshed A. TI - PreSERVE-AMI: CD34+ Cells Improve Cardiac Function, Reduce Events after STEMI DP - 2014 01 TA - MD Conference Express PG - 24--25 VI - 14 IP - 52 4099 - http://mdc.sagepub.com/content/14/52/24.short 4100 - http://mdc.sagepub.com/content/14/52/24.full AB - The intracoronary (IC) infusion of bone marrow mononuclear cells after an STEMI improved cardiac function, including left ventricular ejection fraction, infarct size, and end-systolic volume, and major adverse cardiac events. This article discusses the NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction trial [PreSERVE-AMI; NCT01495364], which looked at IC autologous CD34+ cell therapy for STEMI patients.